Event-Driven Stocks

GRI Bio, Inc.

GRINasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 1 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue————$0$100,000
Operating income−$12.0M−$8.2M−$11.4M−$2.2M−$9.3M−$4.8M
Net income−$12.0M−$8.2M−$13.0M−$3.2M−$9.3M−$4.8M
Total assets$8.7M$5.7M$3.0M$383,000$8.3M$955,000
Total liabilities$2.7M$1.7M$2.7M$2.0M$2.5M$2.4M
Equity$6.0M$4.0M$259,000−$1.6M−$4.8M−$1.5M
EPS (diluted)$-121.80$-1545.55$-5018.09$-24.95$-1.42$-1.07
Shares out.525,3583.2M13.5M6.8M6.8M4.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
—
Net margin
—
Return on equity
−199.0%
Return on assets
−138.0%
Return on capital (ROCE)
−198.9%
Liabilities / assets
30.7%
Debt / equity
0.44×
Book value / share
$11.44
Revenue growth (YoY)
—
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-21.86distress
Accruals / assets
−20.4%clean
Piotroski F-Score
3/7weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
44
/ 100
Profitability 0Growth n/aCatalyst 33Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 1 warning● 2 good
  • Altman Z″ in the distress zone
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026114,0673.6+6.2%
Apr 30, 2026107,3692.3-20.1%
Apr 15, 2026134,3781.0+19.5%
Mar 31, 2026112,4393.5+6.5%
Mar 13, 2026105,6152.2-21.9%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)